Director Kathryn Penkus Corzo resigns from Matinas BioPharma board effective Nov 22, 2024

Matinas BioPharma Holdings, Inc.

Director Kathryn Penkus Corzo resigned from Board effective Nov 22, 2024, citing other professional obligations.
Resignation not due to any material disagreement or change in company direction.
She also resigned from Compensation and Nominating and Corporate Governance Committees.

Matinas BioPharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-048036

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.